3 November, 2026 | The Waldorf Astoria Hotel, Versailles, France
Operationalizing ICH GCP E6(R3)
Join the fifth annual Veeva Clinical Oversight Transformation Forum
An exclusive one-day event. Connect with other senior leaders to advance trial collaboration and oversight.
Reinventing Sponsor Oversight Under ICH E6(R3)
Strategies to align operating models with ICH GCP E6(R3) standards.
Enabling Proactive Risk-Based Oversight
Frameworks for data-driven oversight and real-time risk detection.
Establishing Platform-Based Data Ownership
Peer networking and benchmarking opportunities on oversight and platform strategies.
ICH GCP E6(R3): Processes, Technology & Oversight Evolution
Biopharmas and CROs share strategies for ICH GCP E6(R3) readiness and examine the impact on sponsor oversight. This program provides a comprehensive look at the processes, resources, and technologies for modern-day trial execution.
Connect with Clinical Trial Leaders in Versailles
Join over 80 leaders on 3 November 2026, at the Waldorf Astoria Hotel in Versailles, France for industry-led sessions and networking.
For Executives Responsible for Clinical Oversight Strategy
This complimentary event is for biopharmaceutical industry leaders responsible for setting oversight strategy at their organization.
Previous Speakers
David Appel
UCB
CSM Team Lead
Madeleine Vorster
Syneos Health
Senior Director, Clinical Data Science
Veronica Pomo
Chiesi
Clinical Operations Excellence Lead
Francesca Vaccari
Chiesi
Head of Clinical Feasibility
Evgenia Delyagina
Debiopharm
Head of Transparency & TMF Operations
Emma Forrest
Recordati
Vice President R&D Operations
Elisabeth Coxon
ITM-Oncologics GmbH
Vice President, Head of Global Clinical Operations
Jose Maria Gimenez Arnau
ESTEVE
Chief Scientific & Medical Officer
“I thoroughly appreciated the opportunity to take part in this forum. Thank you for the excellent agenda, engaging presentation and valuable discussions.”
“Events like this truly help drive compliance forward and foster alignment across the industry. Much appreciated.”
“Thanks for offering the possibility to exchange our thoughts on such an important topic and explore the solutions together.”
